Literature DB >> 21831233

Mechanisms linking obesity to hypertension.

J A N Dorresteijn1, F L J Visseren, W Spiering.   

Abstract

Obesity-related hypertension is increasingly recognized as a distinct hypertensive phenotype requiring a modified approach to diagnosis and management. In this review rapidly evolving insights into the complex and interdependent mechanisms linking obesity to hypertension are discussed. Overweight and obesity are associated with adipose tissue dysfunction, characterized by enlarged hypertrophied adipocytes, increased infiltration by macrophages and marked changes in secretion of adipokines and free fatty acids. This results in chronic vascular inflammation, oxidative stress, activation of the renin-angiotensin-aldosterone system and sympathetic overdrive, eventually leading to hypertension. These mechanisms may provide novel targets for anti-hypertensive drug treatment. Recognition of obesity-related hypertension as a distinct diagnosis enables tailored therapy in clinical practice. This includes lifestyle modification and accommodated choice of blood pressure-lowering drugs.
© 2011 The Authors. obesity reviews © 2011 International Association for the Study of Obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21831233     DOI: 10.1111/j.1467-789X.2011.00914.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  57 in total

1.  Relation between adiposity and vascular events, malignancy and mortality in patients with stable cerebrovascular disease.

Authors:  N E M Jaspers; J A N Dorresteijn; Y van der Graaf; J Westerink; L J Kappelle; H M Nathoe; A Algra; F L J Visseren
Journal:  Int J Obes (Lond)       Date:  2017-08-04       Impact factor: 5.095

2.  Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.

Authors:  Sergey V Nedogoda; Alla A Ledyaeva; Elena V Chumachok; Vera V Tsoma; Galina Mazina; Alla S Salasyuk; Irina N Barykina
Journal:  Clin Drug Investig       Date:  2013-08       Impact factor: 2.859

Review 3.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

4.  Improved control of hypertension following laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  Zhiwei Hu; Meiping Chen; Jimin Wu; Qing Song; Chao Yan; Xing Du; Zhonggao Wang
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

5.  Ethnic and gender susceptibility to metabolic risk.

Authors:  Scott M Grundy; Ian J Neeland; Aslan T Turer; Gloria Lena Vega
Journal:  Metab Syndr Relat Disord       Date:  2013-12-10       Impact factor: 1.894

6.  Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population.

Authors:  Helmut Schröder; Rafel Ramos; José M Baena-Díez; Michelle A Mendez; Dolors Juvinyà Canal; Montserrat Fíto; Joan Sala; Roberto Elosua
Journal:  Eur J Nutr       Date:  2013-12-10       Impact factor: 5.614

7.  Association of birthplace and self-reported hypertension by racial/ethnic groups among US adults--National Health Interview Survey, 2006-2010.

Authors:  Jing Fang; Carma Ayala; Fleetwood Loustalot
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

8.  Cafeteria diet increases fat mass and chronically elevates lumbar sympathetic nerve activity in rats.

Authors:  Martin S Muntzel; Omar Ali S Al-Naimi; Alicia Barclay; David Ajasin
Journal:  Hypertension       Date:  2012-10-22       Impact factor: 10.190

9.  Associations of cardiac structure with obesity, blood pressure, inflammation, and insulin resistance in African-American adolescents.

Authors:  Samuel S Gidding; Robert A Palermo; Stephanie S DeLoach; Scott W Keith; Bonita Falkner
Journal:  Pediatr Cardiol       Date:  2013-10-06       Impact factor: 1.655

Review 10.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.